Turn Therapeutics Inc. (TTRX)

NASDAQ: TTRX · Real-Time Price · USD

4.050

+0.030 (0.75%)

May 15, 2026, 4:00 PM EDT - Market closed

Turn Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	-3.19	-1.77	-2.29
Depreciation & Amortization	0.05	0.05	0.04
Stock-Based Compensation	0.42	0.35	0.64
Other Adjustments	-2.21	0.01	0
Changes in Accounts Payable	2.26	0.2	0.21
Changes in Unearned Revenue	-	-	0.02
Changes in Other Operating Activities	0.11	-0.2	0
Operating Cash Flow	-2.56	-1.36	-1.38
Purchases of Intangible Assets	-0.15	-0.1	-0.04
Investing Cash Flow	-0.15	-0.1	-0.04
Issuance of Common Stock	6.92	1.15	0.5
Net Common Stock Issued (Repurchased)	6.92	1.15	0.5
Financing Cash Flow	6.92	1.15	0.5
Net Cash Flow	4.2	-0.31	-0.92
Free Cash Flow	-2.56	-1.36	-1.38
Free Cash Flow Per Share	-0.09	-0.05	-0.05
Levered Free Cash Flow	-0.77	-1.72	-2.02
Unlevered Free Cash Flow	-3.44	-1.75	-2.03

Updated May 11, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q